Lei Chen 0012

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Ping Yin

> Home > Persons > Lei Chen 0012

Publications

2023
[j8]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcmi/YinZLLSLCCH23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcmi/YinZLLSLCCH23
Ping Yin, Junwen Zhong, Ying Liu, Tao Liu, Chao Sun, Xiaoming Liu, Jingjing Cui, Lei Chen, Nan Hong:
Clinical-radiomics models based on plain X-rays for prediction of lung metastasis in patients with osteosarcoma. BMC Medical Imaging 23(1): 40 (2023)
[j7]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcmi/LiuYCSCHL23
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcmi/LiuYCSCHL23
Ying Liu, Ping Yin, Jingjing Cui, Chao Sun, Lei Chen, Nan Hong, Zhentao Li:
Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma. BMC Medical Imaging 23(1): 147 (2023)
[j6]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/bmcmi/LiuYCSCHL23a
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/bmcmi/LiuYCSCHL23a
Ying Liu, Ping Yin, Jingjing Cui, Chao Sun, Lei Chen, Nan Hong, Zhentao Li:
Correction: Radiomics analysis based on CT for the prediction of pulmonary metastases in ewing sarcoma. BMC Medical Imaging 23(1): 157 (2023)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.